Advanced Oncotherapy Plc announced the appointment of Professor Steve Myers OBE and Mr. Hans von Celsing as Non-Executive Directors with immediate effect. In addition, Mr. von Celsing will become Senior Independent Non-Executive Director. Professor Myers' appointment follows the announcement of the Company's intention to do so, on 1 November 2016. At the same time, Tim Lebus, Non-Executive Director, will stand down with immediate effect. Professor Myers has been part of the Advanced Oncotherapy Leadership Team since his appointment as Executive Chairman of the Company's fully owned subsidiary ADAM S.A., in November 2015. Before joining Advanced Oncotherapy, Professor Myers was Head of Medical Applications at CERN in Geneva and before that, was Director of Accelerators and Technology at CERN. Mr. von Celsing was an Adviser to Mevion Medical Systems for eight years and supported their international expansion in Europe and Asia. Mr. von Celsing also joined Elekta, as Executive Vice President, in its early stages in 1985.